UBS Group’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-2,383,825
| Closed | -$2.12M | – | 11382 |
|
|
2022
Q4 | $2.12M | Buy |
2,383,825
+2,149,187
| +916% | +$2.85M | ﹤0.01% | 3337 |
|
|
2022
Q3 | $369K | Sell |
234,638
-900,431
| -79% | -$2.04M | ﹤0.01% | 4600 |
|
|
2022
Q2 | $2.28M | Sell |
1,135,069
-1,345,692
| -54% | -$2.33M | ﹤0.01% | 3048 |
|
|
2022
Q1 | $5.78M | Buy |
2,480,761
+1,631,874
| +192% | +$5.09M | ﹤0.01% | 2403 |
|
|
2021
Q4 | $3.95M | Buy |
848,887
+369,268
| +77% | +$2.29M | ﹤0.01% | 3082 |
|
|
2021
Q3 | $3.66M | Buy |
479,619
+324,010
| +208% | +$2.75M | ﹤0.01% | 2997 |
|
|
2021
Q2 | $1.51M | Sell |
155,609
-139,713
| -47% | -$1.11M | ﹤0.01% | 3832 |
|
|
2021
Q1 | $2.44M | Buy |
295,322
+185,857
| +170% | +$1.96M | ﹤0.01% | 3357 |
|
|
2020
Q4 | $747K | Buy |
109,465
+6,347
| +6% | +$51K | ﹤0.01% | 4256 |
|
|
2020
Q3 | $1.15M | Buy |
103,118
+33,171
| +47% | +$304K | ﹤0.01% | 3536 |
|
|
2020
Q2 | $439K | Sell |
69,947
-28,092
| -29% | -$108K | ﹤0.01% | 4257 |
|
|
2020
Q1 | $180K | Sell |
98,039
-67,624
| -41% | -$195K | ﹤0.01% | 4805 |
|
|
2019
Q4 | $560K | Buy |
165,663
+64,030
| +63% | +$153K | ﹤0.01% | 4738 |
|
|
2019
Q3 | $218K | Buy |
101,633
+75,494
| +289% | +$176K | ﹤0.01% | 5179 |
|
|
2019
Q2 | $69K | Sell |
26,139
-444
| -2% | -$1.6K | ﹤0.01% | 5656 |
|
|
2019
Q1 | $126K | Sell |
26,583
-668,643
| -96% | -$1.75M | ﹤0.01% | 4917 |
|
|
2018
Q4 | $1.67M | Buy |
695,226
+532,674
| +328% | +$1.74M | ﹤0.01% | 3213 |
|
|
2018
Q3 | $715K | Buy |
162,552
+118,669
| +270% | +$658K | ﹤0.01% | 4145 |
|
|
2018
Q2 | $316K | Sell |
43,883
-398,175
| -90% | -$2.71M | ﹤0.01% | 4655 |
|
|
2018
Q1 | $2.28M | Buy |
442,058
+418,848
| +1,805% | +$2.98M | ﹤0.01% | 3023 |
|
|
2017
Q4 | $88K | Buy |
23,210
+21,710
| +1,447% | +$56.5K | ﹤0.01% | 5452 |
|
|
2017
Q3 | $3K | Sell |
1,500
-2,043
| -58% | -$3.75K | ﹤0.01% | 7418 |
|
|
2017
Q2 | $7K | Buy |
3,543
+1,240
| +54% | +$2.42K | ﹤0.01% | 7000 |
|
|
2017
Q1 | $9K | Sell |
2,303
-157,967
| -99% | -$792K | ﹤0.01% | 6701 |
|
|
2016
Q4 | $786K | Buy |
160,270
+32,938
| +26% | +$198K | ﹤0.01% | 3752 |
|
|
2016
Q3 | $986K | Buy |
127,332
+33,815
| +36% | +$228K | ﹤0.01% | 3444 |
|
|
2016
Q2 | $524K | Buy |
93,517
+87,017
| +1,339% | +$556K | ﹤0.01% | 3849 |
|
|
2016
Q1 | $35K | Buy |
6,500
+1,018
| +19% | +$5.92K | ﹤0.01% | 5768 |
|
|
2015
Q4 | $48K | Sell |
5,482
-469
| -8% | -$3.96K | ﹤0.01% | 5861 |
|
|
2015
Q3 | $50K | Buy |
5,951
+5,200
| +692% | +$82.8K | ﹤0.01% | 5840 |
|
|
2015
Q2 | $13K | Sell |
751
-1,860
| -71% | -$23.9K | ﹤0.01% | 7275 |
|
|
2015
Q1 | $30K | Buy |
2,611
+2,060
| +374% | +$23.8K | ﹤0.01% | 6553 |
|
|
2014
Q4 | $6K | Buy |
+551
| New | +$2.79K | ﹤0.01% | 8874 |
|
Other funds holding SRNE
PP
OCM
OFA
CGA
LCM
STB
GA
HFRG
VFA
GBWM